This result was supported by newer data from the FREEDOM trial showing concordant results, although the risk increase fell into borderline significance when nonmetastatic breast cancer was excluded [ 78 , 79 ].
← all excerpts
Molecular Targeted Therapy for the Bone Loss Secondary to Pyogenic Spondylodiscitis Using Medications for Osteoporosis: A Literature Review.
1
—
—